IL-1β-primed mesenchymal stromal cells exert enhanced therapeutic effects to alleviate Chronic Prostatitis/Chronic Pelvic Pain Syndrome through systemic immunity.

导出 OA

翻译打印收藏纠错

作者： Hanchao,Liu ^[1] ; Xinning,Zhu ^[2] ; Xiaohui,Cao ^[3] ; Ani,Chi ^[1] ; Jian,Dai ^[1] ; Zhenqing,Wang ^[4] ; Chunhua,Deng ^[1] ; Min,Zhang ^[5]

作者单位： Department of Andrology, The First Affiliated Hospital of Sun Yat-Sen University, No. 58 Zhongshan Second Road, Guangzhou, China. ^[1] Reproductive Medicine Research Center, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. ^[2] Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, School of Medicine, Hubei Polytechnic University, 16 North Guilin Road, Huangshi, 435003, Hubei, China. ^[3] Guangdong Provincial Key Laboratory of Orthopaedics and Traumatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 51008, China. ^[4] Department of Andrology, The First Affiliated Hospital of Sun Yat-Sen University, No. 58 Zhongshan Second Road, Guangzhou, China. dengchh@mail.sysu.edu.cn. ^[5] Department of Andrology, The First Affiliated Hospital of Sun Yat-Sen University, No. 58 Zhongshan Second Road, Guangzhou, China. zhangm287@mail.sysu.edu.cn. ^[6]

关键词 CP/CPPS IL-1β-primed MSCs Immunoregulation Pain Systemic immunity